Curis' Shares Take Off as FDA Clears IND Application for Monoclonal Anti-VISTA Antibody: https://t.co/l1LZoRiTD3

Shares are up more than 130% the FDA cleared the company's IND Application for CI-8993, its monoclonal anti-VISTA antibody.

$CRIS #cancer #healthcare #stocks https://t.co/0f11rq84cq